Corporate news - Gerresheimer

Corporate news

Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One…
Read more
Revenues up 4.0% to EUR 370.5m Adjusted EBITDA rises 17.5% to EUR 84.7m Adjusted EBITDA margin climbs to 22.8% Adjusted earnings per share…
Read more
Dividend increased to EUR 0.85 per share Large majorities for resolution approving work of Management Board and Supervisory Board   Duesseldorf,…
Read more
First quarter revenues up 13.4% to EUR 342.3m Adjusted EBITDA grows by 29.6% to EUR 66.0m (Q1 2015: EUR 51.0m) Adjusted earnings per share…
Read more
Revenues in financial year 2015 up 6.8% to EUR 1,377.2m Adjusted EBITDA climbs to EUR 277.9m Adjusted earnings per share rise 18.0% to EUR 3.41 …
Read more
Duesseldorf, November 20, 2015 - Today Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, informed Dr. Axel Herberg, Chairman of the…
Read more
Issue substantially oversubscribed, allowing increase in initial amount from EUR 250m to finally EUR 425m Funds used to pay back bridge loan for…
Read more
Revenues up 6.2% to EUR 344.0m, 3.1% on organic basis Adjusted EBITDA rises 9.5% to EUR 68.0m Adjusted net income increases by 28.3% to EUR 29.2m…
Read more
Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs The deal extends Gerresheimer’s footprint in the…
Read more

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com